Latest Breaking News On - Disease director kris ehresmann - Page 13 : comparemela.com

What to know about the Johnson & Johnson COVID-19 vaccine People really do need to get the vaccine that s available to them as soon as they can, said Dr. Rick Kennedy, co-director of Mayo Clinic s Vaccine Research Group. Author: Heidi Wigdahl Updated: 10:23 PM CST March 4, 2021 ROCHESTER, Minnesota The first doses of the Johnson & Johnson COVID-19 vaccine arrived in Minnesota on Wednesday. The state received 45,200 doses this week. Overall in clinical trials, the Johnson & Johnson vaccine was 66% effective in preventing moderate to severe COVID-19 in its global Phase 3 trial but 72% effective in the United States.  Both Pfizer-BioNTech and Moderna reported about 95% effectiveness in their clinical trials. But those numbers don t tell the whole story. 

United statesAlex gorskyErick kennedyTim walzKris ehresmannCenters for diseaseMinnesota department of healthMayo clinic vaccine research groupVaccine research group at mayo clinicCities orthopedics performance centerMayo clinicVaccine researchVaccine research groupFirst johnsonDisease controlGovernor tim walz